Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/08/2005US6962903 Modified annexin proteins and methods for preventing thrombosis
11/08/2005US6962900 Pharmaceutical being used for treating HIV infection, the composition and uses thereof
11/08/2005US6962811 Isolated nucleic acids; therapy, diagnosis
11/08/2005US6962803 Using corynebacterium to ferment diphtheria toxin and treat neoplasms of central nervous system; antitumor agents
11/08/2005US6962802 Growth factor homolog ZVEGF4
11/08/2005US6962801 Protein for blocking platelet adhesion
11/08/2005US6962800 Expression of recombinant human proteins in Tetrahymena
11/08/2005US6962799 Microtubule-associated proteins and tubulins
11/08/2005US6962798 Nucleotide sequences coding heart polypeptide for use in the treatment of cardiomyopathies
11/08/2005US6962797 Nucleic acids encoding PRO615
11/08/2005US6962796 Production of human parathyroid hormone from microorganisms
11/08/2005US6962795 Neutrophil inhibitors
11/08/2005US6962792 cyclin-dependent kinase 4 (CDK4); useful in treatment of tumours and other hyperproliferative disorders
11/08/2005US6962788 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof
11/08/2005US6962784 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
11/08/2005US6962777 VLP-containing compositions produced express conformational, neutralizing epitopes and have high homogeneity and therefore comprise effective diagnostic and prophylactic agents for diagnosis or prevention of papillomavirus infections
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962709 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
11/08/2005US6962708 Chimeric flavivirus vaccines
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005US6962705 Bacterial crystal protein and nucleotide sequences for generating transgenic insect resistant plants
11/08/2005US6962704 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005US6962695 Modification of interferon alpha production
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005US6962688 screening compounds which alter transport of lipid, cholesterol, lipoprotein, which is specifically mediated by SR-BI or a homolog of SR-BI comprising administering compound to a genetically engineered animal, measuring suitable parameters
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/04/2005CA2506334A1 New method for partition and inactivation of viral and prion contaminants
11/03/2005WO2005103302A2 Mutant viral nucleic acids and vaccine containing same
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103270A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants
11/03/2005WO2005103269A2 Generation of plants with altered oil content
11/03/2005WO2005103268A2 Generation of plants with altered oil content
11/03/2005WO2005103266A1 Cry1f and cry1ac transgenic cotton lines and event-specific identification thereof
11/03/2005WO2005103265A1 Multiple heat shock elements
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103251A2 Cancer specific promoters
11/03/2005WO2005103246A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005103087A1 Method for the purification of albumin conjugates
11/03/2005WO2005103082A2 Group 1 mite polypeptide variants
11/03/2005WO2005103080A2 Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
11/03/2005WO2005103079A1 Vaccine composition comprising a class ii cmh ligand coupled with an antigen, method for the preparation and the use thereof
11/03/2005WO2005103078A1 Avian gm-csf
11/03/2005WO2005103077A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005WO2005103076A2 Erythropoietin protein variants
11/03/2005WO2005103075A1 Transcriptional activators involved in abiotic stress tolerance
11/03/2005WO2005103074A2 Combinatorial protein library screening by periplasmic expression
11/03/2005WO2005103073A2 Td antigens
11/03/2005WO2005103071A1 Peptide inhibitors of metalloproteinase activity
11/03/2005WO2005102395A1 Novel use of aim3 acting as a tumor suppressor
11/03/2005WO2005102387A2 Therapeutic use of anti-cs1 antibodies
11/03/2005WO2005102040A1 Tlr ligand and il-1 response-injured animal model
11/03/2005WO2005102039A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005102038A2 Expression of polypeptides in rod outer segment membranes
11/03/2005WO2005101993A2 Metal-containing nanolayered composites, and applications thereof
11/03/2005WO2005085472A3 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/03/2005WO2005084691B1 Method of proliferating precursor cells
11/03/2005WO2005070454A3 A novel process of hepatitis a vaccine preparation
11/03/2005WO2005068635A3 Test system for the identification of antifungal agents
11/03/2005WO2005066363A3 Cancer specific gene ccndbp1
11/03/2005WO2005066211A3 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
11/03/2005WO2005063996A3 Plant activation of insect toxin
11/03/2005WO2005063799A3 Peptide synthesis and deprotection with co-solvent
11/03/2005WO2005063792A3 Methods for recovering cleaved peptide from a support
11/03/2005WO2005059123A3 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders
11/03/2005WO2005055957A3 Influenza immunogen and vaccine
11/03/2005WO2005049099A3 Fibres embedded in a glassy protein
11/03/2005WO2005042732A3 STABLE CELL LINES EXPRESSING HERG1a AND HERG1b
11/03/2005WO2005040341A3 Human prostaglandin ep4 receptor variants and methods of using same
11/03/2005WO2005038010A3 Control of es cell self-renewal and lineage specification, and medium therefor
11/03/2005WO2005038000A3 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
11/03/2005WO2005035570A3 Variants of cd40l protein
11/03/2005WO2005032582A3 Immunogenic compositions for streptococcus pyogenes
11/03/2005WO2005028517A3 SOLUBLE TGF-β TYPE III RECEPTOR FUSION PROTEINS
11/03/2005WO2005025590A3 Use of a dg280 protein product for preventing and treating metabolic disorders
11/03/2005WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
11/03/2005WO2005021586A3 Metabolic engineering of viomycin biosynthesis
11/03/2005WO2005019831B1 Methods for reducing complexity of a sample using small epitope antibodies
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2005005651A3 T cell receptor sequence and method for detecting and treating rheumatoid arthritis
11/03/2005WO2004072240A8 Antiplasmin cleaving enzyme
11/03/2005WO2004066915A3 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof
11/03/2005WO2004060909A3 Increasing production of proteins in gram-positive microorganisms
11/03/2005WO2004018647A3 Methods and compositions for categorizing patients
11/03/2005WO2003068168A3 Helical peptidomimetics and use b-amyloid-associated diseases
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050246799 Receptors for hypersensitive response elicitors and uses thereof
11/03/2005US20050246797 Gene participating in the synthesis of brassinosteroid
11/03/2005US20050246795 Root-specific expansin gene regulating root growth and obstacle-touching stress resistance in the plant
11/03/2005US20050246792 Method for improving corn starch extractability
11/03/2005US20050246789 Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects
11/03/2005US20050246788 Self-incompatible transgenic plants
11/03/2005US20050246784 Method for identifying herbicidally active substances
11/03/2005US20050246782 Transgenic aves producing human polyclonal antibodies
11/03/2005US20050246781 Transgenic production in saliva
11/03/2005US20050246566 Process for providing submodel performance in a computer processing unit
11/03/2005US20050245732 Nucleotide sequences coding plant transcription factor for use as tools in heterologus gene expression; tissue engineering;
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
1 ... 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 ... 2916